Finnish healthtech Treat raises €3M to cut repeat doctor visits
What's the deal? Helsinki healthtech TreatDealroom has a profile for this one. Try Dealroom → has raised €3 million in a pre-seed round led by byFounders and IllusianDealroom has a profile for this one. Try Dealroom →. The platform pairs AI-driven patient intake with remote consultations from licensed physicians, aiming to cut redundant appointments in private care.
Who's behind it? byFounders was an early investor in Lovable, while Illusian is the venture fund backed by Supercell founder Ilkka Paananen. Treat was founded by Sami Marttinen, former chief executive of Swappie; Antti Mauno, a licensed physician; and Onni Wahlberg, a fintech engineer.
How it works: Patients describe symptoms in plain language, and an AI intake tool turns that into a structured summary. Doctors review the context before connecting with patients within minutes, resolving most cases in a single digital visit and routing the rest to a specialist.
Why now? Marttinen says the idea came from personal experience. "Three years ago, my wife had to go through nine repeat doctor visits in private care before receiving a diagnosis. All the necessary information existed, but nobody had the incentive to connect the dots," he said.
The model: Treat makes no revenue from lab tests, clinic visits, or referrals, aligning its incentives with resolving cases quickly. It reaches users through employer-sponsored programs, supplementing existing private health insurance and occupational healthcare. Patient records and personal data stay isolated from public language models, with doctors retaining sole control over clinical decisions.
What could go wrong? The key test is whether Treat can improve access and reduce clinician workload while keeping triage safe and the economics viable.
The signal: The round is a modest early-stage bet in a market where AI is increasingly applied to the care process, not just clinical notes. Sweden's Tandem Health raised $100 million in September to expand an AI assistant into broader clinic operations — a very different scale, but a sign of investor appetite for embedding AI across healthcare workflows. Treat's more patient-facing approach marks a launch-stage Finnish entrant into that trend.
Read more: europacircuit.com
Image credit: "200722-N-AW702-009" by NavyMedicine, public domain (Public Domain Mark 1.0)